Aortic valve replacement after previous coronary artery bypass grafting in a patient with antiphospholipid syndrome
Tóm tắt
We report a 55-year-old female patient with antiphospholipid syndrome secondary to systemic lupus erythematosus. The patient had undergone coronary artery bypass grafting for myocardial infarction due to left main trunk stenosis at the age of 52. Subsequently, she developed aortic insufficiency and underwent aortic valve replacement without any hemodynamic or hemostatic problems. Both coronary and valve disease should be considered in patients with antiphospholipid syndrome secondary to systemic lupus erythematosus.
Tài liệu tham khảo
Asherson RA, Khamashta MA, Ordi-Ros J, et al. The “primary” antiphospholipid syndrome. Major clinical and serological features. Medicine 1989; 68: 366–74.
Harris EN. A reassessment of the antiphospholipid syndrome. J Rheumatol. 1990; 17: 733–5.
Khamashta MA, Ricard Cervera, Asherson RA, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335: 1541–4.
Hamsten A, Norberg R, Bjorkholm M, De Faire U. Antibodies to cardiolipin in young survivors of myocardial infarction: An association with recurrent cardiovascular events. Lancet 1986; 8473: 113–5.
Anderson D, Bell D, Lodge R, et al. Recurrent cerebral ischemia and mitral valve vegetation in a patient with lupus anticoagulant. J Rheumatol 1987; 14: 839–41.
Maja Hojnik, Jacob George, Lea Ziporen, MSc; Yehuda Shoenfeld. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation 1996; 93: 1579–87.
Asherson RA, Harris EN, Gharavi AE, et al. Myocardial infarction in systemic lupus erythematosus and “lupus-like” disease. Arthritis Rheum 1986; 29: 1292–3.